APA

Garcia-Manero G., Roboz G., Walsh K., Kantarjian H., Ritchie E., Kropf P., O'Connell C., Tibes R., Lunin S., Rosenblat T., Yee K., Stock W., Griffiths E., Mace J., Podoltsev N., Berdeja J., Jabbour E., Issa J. J., Hao Y., Keer H. N., Azab M. & Savona M. R. (20191030). Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. : The Lancet. Haematology.

Chicago

Garcia-Manero Guillermo, Roboz Gail, Walsh Katherine, Kantarjian Hagop, Ritchie Ellen, Kropf Patricia, O'Connell Casey, Tibes Raoul, Lunin Scott, Rosenblat Todd, Yee Karen, Stock Wendy, Griffiths Elizabeth, Mace Joseph, Podoltsev Nikolai, Berdeja Jesus, Jabbour Elias, Issa Jean-Pierre J, Hao Yong, Keer Harold N, Azab Mohammad and Savona Michael R. 20191030. Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. : The Lancet. Haematology.

Harvard

Garcia-Manero G., Roboz G., Walsh K., Kantarjian H., Ritchie E., Kropf P., O'Connell C., Tibes R., Lunin S., Rosenblat T., Yee K., Stock W., Griffiths E., Mace J., Podoltsev N., Berdeja J., Jabbour E., Issa J. J., Hao Y., Keer H. N., Azab M. and Savona M. R. (20191030). Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. : The Lancet. Haematology.

MLA

Garcia-Manero Guillermo, Roboz Gail, Walsh Katherine, Kantarjian Hagop, Ritchie Ellen, Kropf Patricia, O'Connell Casey, Tibes Raoul, Lunin Scott, Rosenblat Todd, Yee Karen, Stock Wendy, Griffiths Elizabeth, Mace Joseph, Podoltsev Nikolai, Berdeja Jesus, Jabbour Elias, Issa Jean-Pierre J, Hao Yong, Keer Harold N, Azab Mohammad and Savona Michael R. Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. : The Lancet. Haematology. 20191030.